4 Ways GlaxoSmithKline plc Will Continue To Lag The Biotechnology Sector - Motley Fool UK

17-10-2013 Motley Fool UKComments (0)


GlaxoSmithKline trades at a historic P/E ratio of 13.9, which is below the biotechnology sector average of 17.1. That said, Glaxo's 10-year average historic P/E is around 13, so based on that the company looks to me to be overvalued. Nonetheless, Glaxo ...

Read more on Motley Fool UK

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top